Tirabassi Giacomo, Corona Giovanni, Biagioli Andrea, Buldreghini Eddi, delli Muti Nicola, Maggi Mario, Balercia Giancarlo
Andrology Unit, Division of Endocrinology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
J Sex Med. 2015 Feb;12(2):381-8. doi: 10.1111/jsm.12790. Epub 2014 Dec 2.
Androgen receptor (AR) CAG polymorphism has been found to influence sexual function. However, no study has evaluated its potential to condition sexual function recovery after testosterone replacement therapy (TRT) in a large cohort of hypogonadic subjects.
To evaluate the role of this polymorphism in sexual function improvement after TRT in late-onset hypogonadism (LOH).
Seventy-three men affected by LOH were retrospectively considered. Evaluations were performed before TRT started (time 0) and before the sixth undecanoate testosterone injection.
International Index of Erectile Function (IIEF) questionnaire (erectile function [EF], orgasmic function [OF], sexual desire [SD], intercourse satisfaction [IS], overall satisfaction [OS], and total IIEF-15 score); total and free testosterone and estradiol; AR gene CAG repeat number.
TRT induced a significant increase in total and free testosterone and estradiol. All IIEF domains significantly improved after TRT. AR CAG repeats negatively and significantly correlated with all the variations (Δ-) of sexual function domains, except for Δ-OS. Conversely, Δ-total testosterone was found to be positively and significantly correlated with sexual function domain variations, except for Δ-IS and Δ-OS. Δ-estradiol did not correlate significantly with any of the variations of sexual function domains. After inclusion in generalized linear models, the number of AR gene CAG triplets was found to be independently and negatively associated with Δ-EF, Δ-SD, Δ-IS, and Δ-Total IIEF-15 score, whereas Δ-total testosterone was independently and positively associated with Δ-EF, Δ-OF, Δ-SD, and Δ-Total IIEF-15 score. However, after including time 0 total testosterone in the model, AR gene CAG triplets remained independently and negatively associated only with Δ-EF and Δ-Total IIEF-15 score, whereas Δ-total testosterone was independently and positively associated only with Δ-EF.
Longer length of AR gene CAG repeat tract seems to lower TRT-induced improvement of sexual function in LOH.
雄激素受体(AR)CAG多态性已被发现会影响性功能。然而,尚无研究在一大群性腺功能减退受试者中评估其对睾酮替代疗法(TRT)后性功能恢复的潜在影响。
评估这种多态性在迟发性性腺功能减退(LOH)患者TRT后性功能改善中的作用。
回顾性研究73例受LOH影响的男性。在TRT开始前(时间0)和第6次注射十一酸睾酮前进行评估。
国际勃起功能指数(IIEF)问卷(勃起功能[EF]、性高潮功能[OF]、性欲[SD]、性交满意度[IS]、总体满意度[OS]以及IIEF-15总分);总睾酮、游离睾酮和雌二醇;AR基因CAG重复次数。
TRT使总睾酮、游离睾酮和雌二醇显著升高。TRT后所有IIEF领域均有显著改善。AR CAG重复次数与性功能领域的所有变化(Δ-)呈负相关且显著相关,但与Δ-OS除外。相反,发现Δ-总睾酮与性功能领域变化呈正相关且显著相关,但与Δ-IS和Δ-OS除外。Δ-雌二醇与性功能领域的任何变化均无显著相关性。纳入广义线性模型后,发现AR基因CAG三联体的数量与Δ-EF、Δ-SD、Δ-IS和Δ-IIEF-总得分呈独立负相关,而Δ-总睾酮与Δ-EF、Δ-OF、Δ-SD和Δ-IIEF-总得分呈独立正相关。然而,在模型中纳入时间0的总睾酮后,AR基因CAG三联体仅与Δ-EF和Δ-IIEF-总得分保持独立负相关,而Δ-总睾酮仅与Δ-EF呈独立正相关。
AR基因CAG重复序列长度较长似乎会降低TRT诱导的LOH患者性功能改善。